Here you will find a list with hyperlinks to all the articles (full text or abstracts) online.
2018
Gillespie, NA, et.al
Addiction. 2018 April 24 (abstract).
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids.
Yasmin-Karim, S, et. al
Frontiers in Oncology. 24 April 2018.
Scott, JC, et. al
JAMA Psychiatry. April 18, 2018.
Bradford, AC, et. al
JAMA Internal Medicine. Published online April 2, 2018 (abstract).
Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees
Wen, H, and Hockenberry, JM
JAMA Internal Medicine. Published online April 2, 2018 (abstract).
The Role of Cannabis Legalization in the Opioid Crisis.
Hill, KP, and Saxon, AJ
JAMA Internal Medicine. Published online April 2, 2018.
Wang, X, et.al
Talanta. Vol. 180, 1 April 2018, 229-238 (abstract).
Marijuana Use and Renal Function Among US Adults.
Chang Lu, BS, et. al
The American Journal of Medicine. April 2018, Vol. 131, Issue 4: 408–41 (abstract).
Cannabis and the Opioid Crisis.
Piomelli, D, et. al
Cannabis and Cannabinoid Research. Vol. 3, No.1, Roundtable Discussion, April 2018.
Ko, JY, et. al
Drug and Alcohol Dependence. 2018 Mar 29, vol.187, 72-78 (abstract).
Cannabinoids for Treatment of Dystonia in Huntington’s Disease.
Saft, C, et al.
Journal of Huntington’s Disease. 2018 Mar 16 (abstract).
Bar-Lev Schleider, L, et. al
European Journal of Internal Med.2018 Mar; 49:37-43.
Wang YH, et. al
Planta Medica. 2018 Mar; 84(04): 260-266 (abstract).
Marijuana use and fecundability in a North American preconception cohort study.
Wise LA, et.al
Journal of Epidemiology and Community Health. 2018 Mar;72(3):208-215 (abstract).
Thiele, EA, et. al
Lancet.2018 Mar 17;391(10125):1085-1096 (abstract).
Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly.
Abuhasira, R, et. al
European Journal of Internal Medicine. 2018 Mar; 49:44-50 (abstract).
Crime and the legalization of recreational marijuana.
Dragone, D, et. al
Journal of Economic Behavior & Organization. 20 Feb 2018 (abstract).
Medical Cannabis for the Treatment of Fibromyalgia.
Habib, G, and Artul, S
Journal of Clinical Rheumatology. 2018 Feb 14.
Nordmann, S, et. al
Journal of Viral Hepatitis. 2018 Feb; 25(2):171-179. Epub 2017 Nov 20 (abstract).
Gruber, SA, et. al
Frontiers in Pharmacology. Vol 8, article 983, 17 January 2018.
Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.
Adejumo AC, et. al
Liver International. 2018 Jan 17 (abstract).
Kiertscher SM, et. al
Journal of Neuroimmune Pharmacology. 2018 Jan 16 (abstract).
Sohler NL, et. al
Substance Use and Misuse.2018 Jan 17:1-6 (abstract).
Madeline A. Morris, et. al
Chronic Obstructive Pulmonary Disease. 2018; 5(1): 46-56.
2017
Marijuana use and renal function among US adults.
Lu C, et. al
American Journal of Medicine. 2017 Dec 29 (abstract).
Karoly HC, et. al
Alcoholism Clinical and Experimental Research. 2017 Dec 29 (abstract).
McGuire P, et. al
American Journal of Psychiatry. 2017 Dec 15 (abstract).
Helping settle the marijuana and alcohol debate: evidence from scanner data.
Michele B, et.al
Social Science Research Network. 12 Dec 2017.
Graap H, et. al
International Journal of Eating Disorders. 2017 Dec 1(abstract).
Rizzo MD, et al.
AIDS. 2017 Nov 30 (abstract).
Pressly JD, et. al
Journal of Pharmacology and Experimental Therapeutics. 2017 Nov 29 (abstract).
Cannabis use and hypomania in young people: a prospective analysis.
Marwaha S, et. al
Schizophrenia Bulletin. 2017 Nov 28 (abstract).
Auer R, et. al
Addiction. 2017 Nov 22 (abstract).
Evelina Gavrilova, et. al
The Economic Journal, 16 Nov 2017 (abstract).
WHO, Expert Committee on Drug Dependence.
Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015.
Livingston MD, et. al
American Journal of Public Health. 2017 Nov; 107(11): 1827-1829 (abstract).
Crash fatality rates after recreational marijuana legalization in Washington and Colorado.
Aydelotte, Jayson D, et al.
American Journal of Public Health. 2017 June 22 (abstract).
The Health effects of cannabis and cannabinoids.
The current state of evidence and recommendations for research.
A report of the National Academies of Sciences – Engineering – Medicine.
The National Academies Press. 2017 Washington DC (book).
Giacoppo, Sabrina, et al.
European Journal of Histochemistry. 2017 61: 2749.
Cannabidiol modulates the expression of Alzheimer’s disease-related genes in mesenchymal stem cells.
Libro, Rosalina, et al.
International Journal of Molecular Sciences. 2017 18: 26.
Jadoon, Khalid A, et al.
JCI Insight. June 2, 2017; 2(11): e93760.
The current status of artisanal cannabis for the treatment of epilepsy in The United States.
Sulak, Dustin, et al.
Epilepsy & Behavior. 2017 May 70 part B 328-333 (abstract).
Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial.
Cooper, RE, et al.
European Neuropsychopharmacology. May 30, 2017 (abstract).
Feingold, D, et al.
Psychiatry Research. 2017 May 251: 225-234 (abstract).
Some of the Parts: is marijuana’s “entourage effect” scientifically valid?
Chen, Angus
Scientific American. 2017 April 20.
Marijuana use and serum testosterone concentrations among U.S. males.
Thistle, J E, et al.
Andrology. 2017 April 10 (abstract).
Cannabidiol reduces lung injury by hypoxic-ischemic brain damage in newborn piglets.
Arruza, L, et al.
Pediatric Research. 2017 April 7 (abstract).
Dual therapy targeting the endocannbinoid system prevents experimental diabetic nephropathy.
Barutta, F, et al.
Nephrology Dialysis Transplantation. 2017 April 6.
The impact of current cannabis use on general cognitive function in people with psychotic illness.
Waterreus, A, et al.
Schizophrenia Research. 2017 April 2 (abstract).
Medical marijuana policies and hospitalizations to marijuana and opioid pain reliever.
Shy, Y.
Drug and Alcohol Dependence. 2017 April 1 173: 144-150 (abstract).
Cremon, C, et al.
Alimentary Pharmacology & Therapeutics. 2017 April 45(7): 909-922 (abstract).
Reis, J P, et al.
American Journal of Public Health. 2017 April 107(4): 601-606 (abstract).
Adelli, Goutham, et al.
Investigative Ophthalmology & Visual Science. 2017 58:2167-2179.
Do Val-da Silva, Raquel A, et al.
Frontiers in Pharmacology. 2017 March 8: article 131.
Karpi?ska, O, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2017 March 29 (abstract).
Naftali, T, et al.
Digestive Diseases and Sciences. 2017 March 27 (abstract).
Guida, F, et al.
Scientific Reports. 2017 March 23, 7:375.
Osborne, A L, et al.
Neuropsychopharmacology. 2017 March 22 (abstract).
Chronic pain patients perspectives of medical cannabis.
Piper, B J, et al.
Pain. 2017 March 21 (abstract).
Long lasting effects of chronic heavy cannabis abuse.
Nestoros, J N, et al.
American Journal of Addictions. 2017 March (abstract).
Cannabis use and bone mineral density: NHANES 2007-2010.
Bourne, Donald, et al.
Archives of Osteoporosis. 2017 March 12 29.
Haug, N A, et al.
Addictive Behaviors. 2017 March 9 72:14-20.
Guida, Francesca, et al.
Frontiers in Pharmacology. 2017 March 8: article 95.
Prolonged cannabis withdrawal in young adults with lifetime.
Schuster, R M, et al.
Preventive Medicine. 2017 Feb 27 (abstract).
Effects of tetrahydrocannabinol on glucose uptake in the rat brain.
Miederer, I, et al.
Neuropharmacology. 2017 Feb 20 117: 273-281 (abstract).
Haruna, T, et al.
Pharmacology. 2017 99(5); 259-267 (abstract).
Cannabidiol reduces ethanol, motivation and relapse in mice.
Viudez-Martinez, A, et al.
Addiction Biology. 2017 Feb 13 (abstract).
Bettiga, A, et al.
Scientific Reports. 2017 Feb 13 7: 42157.
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis.
Pagano, E, et al.
Pharmacological Research. 2017 Feb 11 119:227-236 (abstract).
Lucas, P, et al.
International Journal of Drug policy. 2017 Feb 9 42:30-35 (abstract).
van Amerongen, G, et al.
Clinical Therapeutics. 2017 Feb 9 (abstract).
Ruglass, Lesia M, et al.
Journal of Clinical Medicine. 2017 Feb 7 6(2): 14-.
US traffic fatalities, 1985–2014, and their relationship to medical marijuana laws.
Santaella-Tenorio, J, et al.
American Journal of Public Health. 107, no. 2 (February 1, 2017): 336-342 (abstract).
Modulation of human peripheral blood mononuclear cell signaling by medicinal cannabinoids.
Utomo, Wesley, et al.
Frontiers in Molecular Neuroscience. 2017 January 10: article 14.
Lou, Jie, et al.
Frontiers in Pharmacology. 2017 January 8: article 2.
Alberti, Thaís Barbosa, et al.
International Journal of Molecular Sciences. 2017 18 691-.
Aguirre-Velázquez, Carlos G.
Neurology Research International. 2017 Article ID 2985729.
Cannabis as a substitute for opioid-based pain mediacation: patient self-report.
Reimann, Amanda, et al.
Cannabis and Cannabinoid Research. 2017 2 160-166.
McPartland, John M, et al.
Cannabis and Cannabinoid Research. 2017 2 1 87-95.
Cannbinoids in Parkinson’s disease.
Stampanoni Bassi, Mario, et al.
Cannabis and Cannabinoid Research. 2017 2 1: 21-29.
Medical cannabis in the palliation of malignant wounds – a case report.
Maida, Vincent
Journal of Pain and Symptom Management. 2017 Jan 53(1): e4-e6.
Protective effects of trans-caryophyllene on maintaining osteoblast function.
Shan, J, et al.
IUBMB Life. 2017 Jan 69 (1): 22-19 (abstract).
2016
Aizpurua-Olaizola O, et. al
Journal of Natural Products. 2016; 79:324–331.
Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification.
Arno Hazekamp, et.al
Cannabis and Cannabinoid Research. Volume 1.1, 202-215, 2016.
Yamaguchi, M, et al.
International Journal of Molecular Medicine. 2016 Dec 38(6): 1940-1946 (abstract).
Todd, S M, et al.
European Journal of Neuropsychopharmacology. 2016 Dec 30 (abstract).
Wang, D, et al.
Neuroscience. 2016 Dec 30 (abstract).
Falkstedt, D, et al.
Stroke. 2016 Dec 27 (abstract).
Annunziata, P, et al.
Journal of Neuroimmunology. 2016 Dec 23 (abstract).
Mitochondrial functions of THP-1 monocytes following the exposure to selected natural compounds.
Schultze, N, et al.
Toxicology. 2016 Dec 21 377: 57-63 (abstract).
Ceprián, M, et al.
Neuropharmacology. 2016 Dec 21, 116: 151-159 (abstract).
Synergistic attenuation of chronic pain mu opioid and cannabinoid receptor 2 agonists.
Grenald, S A, et al.
Neuropharmacology. 2016 Dec 20 116: 59-70 (abstract).
Mokrysz, C, et. al
Translational Psychiatry. 2016 Nov 29.
Strisciuglio, C, et al.
Journal of Clinical Gastroenterology. 2016 Nov 21 (abstract).
Santos, A, et al.
Chemico-Biological Interactions. 2016 Nov 18 261: 86-95 (abstract).
Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.
Treat, L, et al.
Epilepsia. 2016 Nov 18 (abstract).
Prevalence and patterns of marijuana use in young adults with inflammatory bowel disease.
Phatak, U P, et al.
Journal of Pediatric Gastroenterology and Nutrition. 2016 Nov 14 (abstract).
Johnson, J, et al.
Drug and Alcohol Dependence. 2016 Nov 4 170: 1-8 (abstract).
Jadoon, K A, et al.
Diabetes Care. 2016 Oct 39(10): 1777-86 (abstract).
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo.
Barbado, M V, et al.
International Journal of Cancer. 2016 Oct 25 (abstract).
Crystal structure of the human cannabinoid receptor CB1.
Hua, Tian, et al.
Cell. 2016 Oct 20 167: 750-762 (abstract).
Gajardo-Gómez, R, et al.
Glia. 2016 Oct 19 (abstract).
Sartim, A G, et al.
Neuroscience. 2016 Oct 19 (abstract).
Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.
Juhasz, G, et al.
Genes, Brain and Behavior. 2016 Oct 19 (abstract).
Tan, Q, et al.
Brain Research. 2016Oct 18 (abstract).
Cranford, J A, et al.
Drug and Alcohol Dependence. 2016 Oct 15 169: 41-47 (abstract).
Murillo-Rodriguez, E, et al.
Neuroscience. 2016 Oct 13 (abstract).
Medical cannabis and mental health; a guided systematic review.
Walsh, Z, et al.
Clinical Psychology Review 2016 Oct 12 51: 15-29 (abstract).
Shohet, A, et al.
European Journal of Pain. 2016 Oct 10 (abstract).
Biovailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers.
Parikh, N, et al.
Clinical Pharmacology. 2016 Oct 12 8: 155-162.
Shannon, S, et al.
The Permanente Journal. 2016 Oct 12 20(4) (abstract).
Gruber, Staci A, et al.
Frontiers in Pharmacology. 2016 Oct 7: article 355.
Pagano, Ester, et al.
Frontiers In Pharmacology. 2016 Oct 7: article 341.
Soundara Rajan, T, et al.
Journal of Cellular Biochemistry. 2016 Oct 7 (abstract).
Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.
Ishida, JH, et. al
Clinical Journal of the American Society of Nephrology.Oct 06, 2017 vol. 12 no. 10: 1578-1587.
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.
Vaia, M, et al.
European Journal of Pharmacology. 2016 Oct 5 791: 669-674 (abstract).
Bertolino, B, et al.
CNS Neuroscience & Therapeutics. 2016 Oct 4 (abstract).
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Hess, E J, et al.
Epilepsia. 2016 Oct 57(10): 1617-1624 (abstract).
Lawn, W, et. al
Psychopharmacology (Berl). 2016 Oct 233 (19-20):3537-52.
Abalo, R, et al.
Neurogastroenterology & Motility. 2016 Sep 30 (abstract).
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice.
Bozkurt, T E, et al.
Respiratory Physiology & Neurobiology. 2016 Sep 231: 7-13 (abstract).
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats.
Peres, Fernanda, et al.
Frontiers in Pharmacology. 2016 Sep 28 7: article 343.
Mohammad, N, et al.
CNS & Neurological Disorders- Drug Targets. 2016 Sep 27 (abstract).
Xu, J, et al.
European Journal of Neurosciences. 2016 Sep 26 (abstract).
Got munchies? Estimating the relationship between marijuana use and body mass index.
Beulaygue, I C, et al.
Journal of Mental Health Policy and Economics. 2016 Sep 19(3): 123-140 (abstract).
Wilsey, B, et al.
Journal of Pain. 2016 Sep 17(9): 982-1000 ( abstract).
Impact of cannabis, cannabinoids and endocannabinoids in the lungs.
Turcotte, Caroline, et al.
Frontiers in Pharmacology. 2016 Sep 15 7: article 317.
Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure.
De Sousa Fernandes Perna, E B, et al.
Psychopharmacology. 2016 Sep, vol. 233, Issue 18, 3331-3340.
Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.
Brierly, D I, et al.
Psychopharmacology (Berl). 2016 Aug (abstract).
Martin-Saldaña, S, et al.
PLoS One. 2016 Aug 26 11(8).
Szczesniak, A M, et al.
Neuropharmacology. 2016 Aug 25 (abstract).
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit.
Massot-Tarrús, A, et al.
Epilepsy Behavior. 2016 Aug 25 (abstract).
Severe motor and vocal tics controlled with Sativex®.
Trainor, D, et al.
Australasian Psychiatry. 2016 Aug 24 (abstract).
Wilkinson, A L, et al.
Journal Adolescent Health. 2016 Aug 23 (abstract).
Schoeler, Tabea, et al.
Lancet Psychiatry. 2016 August 22.
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.
Abbassian H, et al.
British Journal of Pharmacology. 2016 Aug 21 (abstract).
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer
MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.
Takeda, S, et al.
Journal of Natural Medicines. 2016 Aug.16 (abstract).
Aso, E, et al.
Journal of Alzheimer’s Disease. 2106 Aug 10 (abstract).
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats.
Suleymanova, E M, et al.
Neuroscience. 2016 Aug 9. (abstract).
Sex-dependent effects of cannabis-induced analgesia.
Cooper, Z D, et al.
Drug and Alcohol Dependence. 2016 Aug 5 (abstract).
Romano, B, et al.
Pharmacological Research. 2016 Aug.3 (abstract).
Javed, Hayate, et al.
Frontiers in Neuroscience. 2016 August 2 10: article 321.
Effective treatment of spasticity using dronabinol in pediatric palliative care.
Kuhlen, M, et al.
European Journal of Paediatric Neurology. 2016 July 30 (abstract).
The availability of medical marijuana dispensary and adolescent marijuana use.
Shi, Y
Preventive Medicine. 2016 July 25 91: 1-7 (abstract).
Medical marijuana laws reduce prescription medication use in medicare part D.
Bradford, A C, et al.
Health Alf (Millwood). 2016 July 1 35(7): 1230-1236 (abstract).
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids.
Currais, Antonio, et al.
NPJ Aging and Mechanisms of Disease 2. 2016 June 23.
El Marroun, H, et al.
Biological Psychiatry. 2016 June 15 179(12): 971-979 (abstract).
Indirect modulation of the endocannabinoid system by specific fractions of nutmeg total extract.
El-Alfy, Abir T, et al.
Pharmaceutical Biology. 2016 June 13.
Opioid and cannabinoid synergy in a mouse neuropathic pain model.
Kazantzis, N P, et al.
British Journal of Pharmacology. 2016 June 9 (abstract).
Sagar, Kelly, et al.
PLOS One. 2016 June 8.
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.
Patel, R R, et al.
Brain. 2016 June 5 (abstract).
Wang, L L, et al.
European Journal of Pharmacology. 2016 June 3 786: 128-136 (abstract).
Trigo, J M, et al.
Journal of Addiction Medicine. 2016 June 3 (abstract).
Marijuana use and its effects in pregnancy.
Chabarria, K C, et al.
American Journal of Obstetrics and Gynecology. June 2 (abstract).
Zaurova, M, et al.
Journal of Medical Toxicology.2016 June 2 (abstract).
The derivation of modern cannabis varieties.
Rahn, Bailey, et al.
Critical Reviews in Plant Sciences. 2016 35(5/6): Cannabis.
Medicinal uses of marijuana and cannabinoids.
Grotenhermen, Franjo, et al.
Critical Reviews in Plant Sciences. 2016 35(5/6): Cannabis.
Meier, M H, et al.
JAMA Psychiatry. 2016 June 1 (abstract).
Effects of medical marijuana on migraine headache frequency in an adult population.
Rhyne, D N, et al.
Pharmacotherapy. 2016 May 36(5): 505-510 (abstract).
Pain, cannabis species and cannabis use disorders.
Cohen, N L, et al.
Journal of studies on alcohol and drugs. 2016 May 77(3): 515-520 (abstract).
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.
Elbaz, Mohamad, et al.
Oncotarget. 2016 May 27.
I use weed for my ADHD: a qualitative analysis of online forum discussions on cannabis use and ADHD.
Mitchell, John T, et al.
PLOS ONE. 2016 May 26.
Grey matter changes associated with heavy cannabis use; a longitudinal sMRI study.
Koenders, Laura, et al.
PLOS One. 2016 May 25.
Andresen, S R, et al.
Pain. 2016 May 25 (abstract).
Kelly, E M, et al.
Clinical and Infectious Diseases. 2016 May 25 (abstract).
Effects of delta-9-tetrahydrocannabinol and cannabidiol on cisplatin-induced neuropathy in mice.
Harris, Hannah M, et al.
Planta Medica. 2016 May 23 82: 1169-1172.
Manuel, I, et al.
Neuroscience. 2016 May 17 329: 284-293 (abstract).
Haupts, M, et al.
European Neurology. 2016 May 10 75(5-6): 236-243 (abstract).
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Patti, F, et al.
Journal of Neurology Neurosurgery and Psychiatry. 2016 May 9.
López-Sendón Moreno, J L, et al.
Journal of Neurology. 2016 May 9 (abstract).
Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors
produce antipruritic effect in mice.
Yesilyurt, O, et al.
Archives of Dermatological Research. 2016 April 28 (abstract).
Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis.
Hazekamp, Arno
Frontiers in Pharmacology. 2016 April 27 7: article 108.
Sonego, A B, et al.
Behavioural Brain Research. 2016 April 27 309: 22-28 (abstract).
Oláh, A, et al.
Experimental Dermatology. 2016 April 20 (abstract).
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells
in HIV-HCV co-infected patients (ANRS CO-HEPAVIH French cohort).
Marcellin, F, et al.
Drug and Alcohol Review. 2016 April 13 (abstract).
Cannabidiol promotes browning in 3T3-L-1 adipocytes.
Parray, H A, et al.
Molecular and Cellular Biochemistry. 2016 April 11 (abstract).
Cannabis and cannabinoids (PDQ®). Health professional version.
PDQ Integrative, alternative and complementary therapies editorial board.
Published online. 2016 April 8.
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical
5-HT/glutamate neurotransmission: role of 5-HT1A receptors.
Linge, R, et al.
Neuropharmacology. 2016 April 103: 16-26 (abstract).
Poster presentation American College of Cardiology 2016 Scientific Sessions.
2016 April 3 (abstract).
Cannabis and cannabinoids (PDQ®). Patient version.
PDQ integrative, alternative and complementary editorial board.
Published online. 2016 April 1.
Effects of fixed or self-titrated dosages of Savitex on cannabis withdrawal and cravings.
Trigo, J M, et al.
Drug and Alcohol Dependence. 2016 April 1 161: 298-306 (abstract).
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Marinelli, L, et al.
International Journal of Clinical Psychopharmacology. 2016 Mar. 21 (abstract).
Cannabis and cancer: toward a new understanding.
Ware, M A
Current Oncology. 2016 23 Suppl.2: S5-S6.
Perrier, L
Current Oncology. 2016 23 Suppl.2: S7.
Integrating cannabis into clinical cancer care.
Abrams, D I
Current Oncology. 2016 23 Suppl.2: S8-S14.
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.
Fischer, T, et al.
Current Oncology. 2016 23 Suppl.2: S15-S22.
Anticancer mechanisms of cannabinoids.
Velasco, G, et al.
Current Oncology. 2016 23 Suppl.2: S23-32.
Use of cannabinoids in cancer care: palliative care.
Aggarwal, S K
Current Oncology. 2016 23 Suppl. 2: S33-S36.
Gunn, J K L, et al.
BMJ Open. 2016 6(4).
Boehnke, K F, et al.
Journal of Pain. 2016 Mar. 18 (abstract).
Köfalvi, A, et al.
Neuropharmacology. 2016 Mar. 11 (abstract).
Wall, M M, et al.
International Journal of Drug Policy. 2016 Mar. 29:9-13 (abstract).
Prohedonic effect of cannabidiol in a rat model of depression.
Shoval, G, et al.
Neuropsychobiology.2016 73(2): 123-129 (abstract).
Metabolic syndrome in people with a psychotic illness: is cannabis protective?
Waterreus, A, et al.
Psychological Medicine.2016 Mar. 11: 1-12 (abstract).
Bakali, E, et al.
International Urogynecology Journal. 2016 Mar. 4 (abstract).
Lu, C, et al.
Cellular and Molecular Neurobiology. 2016 Mar. 2 (abstract).
Combined treatment with morphine and ?9-tetrahydrocannibinol (THC) in rhesus monkeys:
antinociceptive tolerance and withdrawal.
Gerak, L R, et al.
Journal of Pharmacology and Experimental Therapeutics. 2016 Mar. 2 (abstract).
An event-related potential study on the effects of cannabis on emotion processing.
Troup, Lucy J, et al.
PLOS ONE. 2016 Feb. 29.
Brown, S J, et al.
BMJ Open. 2016 Feb. 23.
CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience.
Tzadok, M, et al.
Seizure.2016 Feb. 35: 41-44 (abstract).
Ossala, C A, et al.
Journal of Periodontology. 2016 Feb. 5:1-17 (abstract).
Adverse effects of cannabis on adolescent brain development: a longitudinal study.
Camchong, J, et al.
Cerebral Cortex. 2016 Feb. 23 (abstract).
Mokrysz, C, et. al
Journal of Psychopharmacology. 2016 Feb 30(2): 159-168.
Patti, Francesco
European Neurology. 2016 75(suppl.1): 9-12.
Trojano, Maria
European Neurology. 2016 75(suppl.1): 4-8.
THC:CBD (Sativex) in daily practice: available data from UK, Germany and Spain.
Fernández, Oscar
European Neurology. 2016 75(suppl.1): 1-3.
Fatty acid amide hydrolase inhibitors anti-invasive and antimetastatic effects on lung cancer cells,
Winkler, K, et al.
Oncotarget. 2016 Feb. 22 (abstract).
Cannabis effects on driving longitudinal control with and without alcohol.
Hartman, R L, et al.
Journal of Applied Toxicology. 2016 Feb.18 (abstract).
Del Rio, C, et al.
Scientific Report. 2016 Feb. 18 6:21703 (abstract).
Cannabis effects on driving longitudinal control with and without alcohol.
Hartman, R L, et al.
Journal of Applied Toxicology. 2016 Feb. 18 (abstract).
Haroutounian, S, et al.
Clinical Journal of Pain. 2016 Feb. 17 (abstract).
Bozkurt, T E, et al.
European Journal of Pharmacology. 2016 Feb. 16 (abstract).
Meta-analysis of the association between the level of cannabis use and risk of psychosis.
Marconi, A, et al.
Schizophrinia Bulletin. 2016 Feb.15 (abstract).
Endocannabinoid concentrations in hair are associated with PTSD symptom severity.
Wilker, S, et al.
Psychoneuroendocrinology. 2016 Feb. 12 67: 198-206 (abstract).
Cannabis and psychosis: a critical overview of the relationship.
Ksir, C, et al.
Current Psychiatry Reports. 2016 Feb. 18(2): 12 (abstract).
Babatope, T, et al.
Psychiatric Quarterly. 2016 Feb. 13 (abstract).
Frei, R B, et al.
Allergy. 2016 Feb. 6 (abstract).
Marijuana use patterns and sleep among community-based young adults.
Conroy, D A, et al.
Journal of Addiction Disorders. 2016 35(2): 135-43 (abstract).
Prior cannabis use is associated with outcome after intracerebral hemorrhage.
Di Napoli, M, et al.
Cerebrovascular Diseases. 2016 Jan. 29 41(5/6): 248-255 (abstract).
Helle, S, et al.
Schizophrenia Research. 2016 Jan. 170(1): 217-221 (abstract).
Prior cannabis use is associated with outcome after intracerebral hemorrhage.
Di Napoli, M, et al.
Cerebrovascular Disease. 2016 Jan. 29 41(5-6): 248-255 (abstract).
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies.
Jackson, NJ, et. al
Proceedings of the National Academy of Sciences. January 19, 2016.
The cannabis sativa versus cannabis indica debate; an interview with Ethan Russo, MD.
Piomelli, Danielle, et al.
Cannabis and Cannabinoid Research. 2016 1(1): 44-46.
Review on clinical studies with cannabis and cannabinoids 2010-2014.
Kowal, Mikael A, et al.
Cannabinoids. 2016 11(special issue): 1-18.
Cannabis use, depression and anxiety: a 3-year prospective population-based study.
Danielsson, Anna-Karin, et al.
Journal of Affective Disorders. 2016 193: 103-108.
Nam, Gaewon, et al.
Annals of Dermatology. 2016 28(1): 22-29.
Training and practices of cannabis dispensary staff.
Haug, Nancy A, et al.
Cannabis and Cannabinoid Research. 2016 1 1: 244-251.
Cheer, Joseph F, et al.
Cannabis and Cannabinoid Research. 2016 1 1: 54-58.
Medicinal Cannabis: in vitro validation of vaporizers for the smoke-free inhalation of cannabis.
Lanz, Christian, et al.
PLOS ONE. 2016 January.
Impact of adolescent marijuana use on intelligence: results from two longitudinal twin studies.
Jackson, N J, et al.
Proceedings of the National Academy of Sciences U S A. 2016 Jan. 19 (abstract).
Dunn, Sara L, et al.
Cannabis and Cannabinoid Research. Vol. 1, Issue 1, Jan. 14, 2016.
Russo, Margherita, et al.
Pain Medicine. 2016 January 13.
Shelef, A, et al.
Journal of Alzheimers Disease. 2016 Jan. 12 (abstract).
Effects of medical marijuana on migraine headache frequency in an adult population.
Rhyne, D N, et al.
Pharmacotherapy. 2016 Jan. 9 (abstract).
Lee, W S, et al.
Molecular Medicine. 2016 Jan. 8 (abstract).
Kozela, Ewa, et al.
Journal of Neuroinflammation. 2016 13: 136.
Bonn-Miller, Marcel O, et al.
Cannabis and Cannabinoid Research. 2016 1(1): 252-261.
Dronabinol has preferential antileukemic activity in acute lymphoid differentiation patterns.
Kampa-Schittenhelm, Kerstin Maria, et al.
BMC Cancer. 2016 16:25.
2015
Giese, M, et al.
Journal of AOAC International. Vol. 98, No. 6, 2015, 1503-1522.
Feingold, D, et al.
European Neuropsychopharmacology. 2015 Dec. 29 (abstract).
Bianconi, F, et al.
Psycological Medicine. 2015 Dec. 16 1-9 (abstract).
Zoja, C, et al.
Nephron. 2015 Dec. 9 (abstract).
Pharmaceutical CBD (cannabidiol) shows promise for children with severe epilepsy.
Significant seizure reduction in studies using CBD in combination with AEDs.
American Epilepsy Society.
Science Daily. 2015 Dec. 7.
Head and neck cancer among marijuana users; a meta-analysis of matched case-control studies.
de Carvalho, M F, et al.
Archives of oral Biology. 2015 Dec. 60(12): 1750-1755 (abstract).
Cluny, Nina L, et al.
PLOS One 2015 December 3.
Paolicelli, D, et al.
Journal of clinical Pharmacology. 2015 Nov. 26 (abstract).
Cannabis liberalization and adolescent cannabis use: a cross-national study in 38 countries.
Shi, Yuyan, et al.
PLOS One 2015 November 25.
Controlled release tablet formulation containing natural 9 tetrahydrocannabinol.
Punyamurthula, N S, et al.
Drug Development and Industrial Pharmacy. 2015 Nov. 20: 1-25 (abstract).
Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice.
Verty, A N A
Plos One. 2015 November 20.
Englund, A, et al.
Journal of Psychopharmacology. 2015 Nov. 17 (abstract).
Lowin, Torsten, et al.
Arthritis Research & Therapy. 2015 Nov. 14 17: 321.
Sideli, L, et al.
Early Intervention in Psychiatry. 2015 Nov. 12 (abstract).
Jayant, S, et al.
Pharmacological Biochemical Behavior. 2015 Nov. 11 (abstract).
Heavy cannabis users at elevated risk of stroke: evidence from a general population survey.
Hemachandra, D, et al.
Australian and New Zealand Journal of Public Health. 2015 Nov. 11 (abstract).
Medicinal value of cannabinol (CBN)-Medical Marijuana Inc. 2015 Nov. 11.
Caltana, L, et al.
Journal of Neurochemistry. 2015 Nov. 135(3): 616-629 (abstract).
Vidot, D C, et al.
American Journal of Medicine. 2015 Nov. 5 (abstract).
Blanco, Eduardo, et al.
Frontiers in Neuroanatomy. 2015 November 3.
Lucas, Philippe, et al.
Drug and Alcohol Review. 2015 (abstract).
Cannabis species and cannabinoid concentration among sleep-disturbed medicinal cannabis users.
Belendiuk, Katherine A, et al.
Addictive Behaviors. 2015 November 50: 176-181 (abstract).
Loflin, Mallory, et al.
Canadian Journal of Respiratory Therapy. 2015 51(1): 7-9.
Moreno-Martet, M, et al.
Multiple Sclerosis and Related Disorders. 2015 Nov. 4(6) 505-511 (abstract).
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model arthritis.
Hammell, D C, et al.
European Journal of Pain. 2015 Oct. 30 (abstract).
Kogan, N M, et al.
Journal of Bone and Mineral research. 2015 Oct 30 (10) 1905-1913 (abstract).
Medicinal value of cannabinol (CBN)-Medical Marijuana Inc. 2015 Oct.29.
Endocannabinoid signaling in autism.
Chakrabarti, Bhismadev et al.
Neurotherapeutics. 2015 Oct 12(4): 837-847.
Finding cannabinoids in hair does not prove cannabis consumption.
Moosmann, Bjoern et al.
Nature Scientific Reports. 2015 October 7.
Haney, M, et al.
Neuropsychopharmacology.2015 Oct. 40(11): 2489-2498 (abstract).
A runner’s high depends on cannabinoid receptors in mice.
Fuss, J, et al.
Proceedings of the National Academy of Sciences USA. 2015 112(42): 13105-8 (absract).
Marwaha, S, et al.
Psychiatry Research. 2015 Sep. 30, 229(1-2): 49-56 (abstract).
Relationship between cannabis and psychosis: reasons for use and associated clinical variables.
Mané, A, et al.
Psychiatry Research. 2015 Sep. 30, 229(1-2): 70-74 (abstract).
Association between marijuana use and adverse obstetrical and neonatal outcomes.
Warshalk, C R, et al.
Journal of Perinatology. 2015 Sep. 24 (abstract).
Grayson, Michelle.
Nature Supplement. 2015 September 24, 525 No. 750_supp ppS1-S18.
Actions of the dual FAAH/MAGL inhibitor JZL 195 in a murine neuropathic pain model.
Adamson Barnes, N S, et al.
British Journal of Pharmacology. 2015 Sep. 23 (abstract).
Maguire, D R, et al.
Behavioural Pharmacology. 2015 Sep. 21 (abstract).
Todd, S M, et al.
British journal of Pharmacology. 2015 Sep.17 (abstract).
Cannabis for the management of pain: assessment of safety study (COMPASS).
Ware, M A, et al.
Journal of Pain. 2015 Sep. 16 (see separate binder).
Patterns of cannabis use in patients with inflammatory bowel disease: a population based analysis.
Weiss, A, et al.
Drug and Alcohol Dependence. 2015 Sep. 14 (abstract).
Lucas, P, et al.
Drug and Alcohol Review. 2015 Sep. 14 (abstract).
Rzepa, Ewelina, et al.
International Journal of Neuropsychopharmacology. 2015 Sep 14, 1-7.
Potential therapeutic value of a novel FAAH inhibitor for the treatment of anxiety.
Marco, Eva M, et al.
PLOS One. 2015 September 11.
Endocannabinoid modulation of predator stress-induced long-term anxiety in rats.
Lim, J, et al.
Neuropsychopharmacology. 2015 Sep. 11 (abstract).
Anadamide mediates cognitive judgement bias in rats.
Kregiel, J, et al.
Neuropsychopharmacology. 2015 Sep. 9 (abstract).
The effect of medical marijuana laws on body weight.
Sabia, Joseph J, et al.
Health Economics 2015 September 8.
White, H R, et al.
Drug and Alcohol Dependence. 2015 Sep. 5 (abstract).
Sophocleous, Antonia, et al.
Journal of Biological Chemistry. 2015 Sep. 4 290(36): 22049-60.
Bisaga, A, et al.
Drug and Alcohol Dependence. 2015 Sep. 1 154: 38-45 (abstract).
The genetic structure of marijuana and hemp.
Sawler, Jason, et al.
PLOS One. 2015 Aug. 26.
Shared predisposition in the association between cannabis use and subcortical brain structure.
Pagliaccio, David, et al.
JAMA Psychiatry 2015 August 26.
Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice.
Schmitz, K, et al.
International Journal of Obesity. 2015 Aug. 25 (abstract).
Ho, W S, et al.
British Journal of Pharmacology. 2015 Aug. 21 (abstract).
Sativex ® and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Leocani, L, et al.
Journal of Neurology. 2015 Aug. 20 (abstract).
Gundersen, T D, et al.
American of Epidemiology. 2015, 182(6): 473-481.
Endocannabinoid regulation of amyloid-induced neuroinflammation.
Vàzquez, C, et al.
Neurobiology of Aging. 2015 Aug. 15 (abstract).
Gobira, P H, et al.
Neurotoxicology. 2015 Aug. 15 (abstract).
Hjorthøj, C, et al.
Lancet Psychiatry. 2015 Aug. 12 (abstract).
Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis.
Arnold, C, et al.
Schizophrenia Research. Aug. 7 (abstract).
Bechtold, J, et al.
Psychology of Addictive Behaviors. 2015 Aug. 3 (abstract).
Mounsey, R B, et al.
Experimental Neurology. Aug. 2 273: 36-44 (abstract).
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
Betthauser, Kevin, et al.
American Journal of Health-System Pharmacy. 2015 August 72: 1279-1284.
No additive effect of cannabis on cognition in schizophrenia.
Power, B D, et al.
Schizophrenia Research. 2015 July 30 (abstract).
Alshaarawy, O, et al.
Epidemiology. 2015 July 26 (4): 597-600 (abstract).
Natural outcome of cannabis use disorder: a three-year longitudinal follow-up.
Feingold, D, et al.
Addiction. 2015 July 25 (abstract).
Gunduz, O, et al.
European Journal of Pain. 2015 July 24 (abstract).
Nettekoven, M, et al.
ChemMedChem.2015 July 21 (abstract).
Hancock-Allen, Jessica B, et al.
Morbidity and Mortality Weekly Report. 2015 July 24 64(28): 771-772.
Time-dependent protection of CB2 receptor agonist in stroke.
Yu, Seong-Jin, et al.
PLOS One. 2015 July 17 10(7).
Wen, J, et al.
Neuropharmacology. 2015 July 17 99: 196-209 (abstract).
Cannabis allergy: what do we know anno 2015.
Decuyper, I, et al.
Archivum Immunologiae et Therapiae Experimentalis. 2015 July 16 (abstract).
Guo, Z, et al.
Clinical and Experimental Pharmacology and Physiology. 2015 July 14 (abstract).
Cannabinoids and terpenes as chemotaxonomic markers in cannabis.
Elzinga, S, et al.
Natural Products Chemistry & Research. 2015 3(4): 181.
Bisaga, A, et al.
Drug and Alcohol Dependence. 2015 July 8 (abstract).
Cone, E J, et al.
Journal of Analytical Toxicology. 2015 July 2 (abstract).
Cannabis use and reduced risk of insulin resistance analysis (ANRS CO13 HEPAVIH).
Carrieri, Maria Patrizia, et al.
Clinical Infectious Diseases. 2015 July 1 61.
Abrams, Donald I, et al.
Clinical Pharmacology & Therapeutics. 2015 June 97(6): 575-586.
Medical marijuana for treatment of chronic pain and other medical and psychiatric problems.
Hill, Kevin P
JAMA. 2015 313 June 23/30 (24): 2474-2483.
Are cannabidiol and 9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland, John M, et al.
British Journal of Pharmacology. 2015 172: 737-753.
Cannabis sativa: the unconventional “weed” allergen.
Ocampo, Thad L, et al.
Annals of Allergy, Asthma & Immunology. 2015 114: 187-92
Shakoor, S, et al.
Psychiatry Research. 2015 June 30 227(2/3): 144-51 (abstract).
Cannabinoid dose and label accuracy in edible medical cannabis products.
Vandrey, Ryan, et al.
JAMA. 2015 June 23/30 313(24): 2491-2493.
Medical marijuana. Is the cart before the horse.
D’Souza, Deepak Cyril, et al.
JAMA. 2015 June 23/30 313(24): 2431-2432.
Gilman, Jodi M, et al.
The Journal of Neuroscience. 2015 June 28 35(4): 1505-1512.
Stanley, C P, et al.
Cardiovascular Research. 2015 June 19 (abstract).
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 1994:
results from annual, repeated cross-sectional surveys.
Hasin, Deborah S, et al.
The Lancet (psychiatry). 2015 June 16.
Lynch, M E, et al.
Journal of Neuroimmune Pharmacology. 2015 June 10 (2): 293-301 (abstract).
Feng, Y, et al.
Journal of Cardiovascular Research. 2015 June 9 (abstract).
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: a randomized controlled trial.
van den Elsen, G A, et al.
Neurology. 2015 June 9 84(23): 2338-2346 (abstract).
Rock, E M, et al.
Behavioral Neuroscience. 2015 June 129 (3): 368-70 (abstract).
Cannabinoids for medical use: a systematic review and meta-analysis.
Whiting, Penny F, et al.
JAMA. 2015 313(24): 2456-2473.
Hartman, Rebecca L, et al.
Clinical Chemistry. 2015 61(6): 850-869.
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.
Presley, Chaela, et al.
Pharmacology, Research & Perspectives. 2015 3(4): 1-16.
Baron, E P
Headache. 2015 May 25 (abstract).
Fu W, et al.
Neuroscience Letters. 2015 May 19 595:1-6 (abstract).
Alshaarawy, O, et al.
Epidemiology. 2015 May 14 (abstract).
CB1 receptors modulate affective behaviour induced by neuropathic pain.
Rácz, I, et al.
Brain Research Bulletin. 2015 May 114: 42-48 (abstract).
Perron, Brian E, et al.
Journal of Studies on Alcohol and Drugs. 2015 May 76(3): 406-418.
The antitumor activity of plant-derived non-psychoactive cannabinoids.
McAllister, Sean D, et al.
Journal of Neuroimmune Pharmacology. 2015 April.
Differential role of cannabinoids in the pathogenesis of skin cancer.
Glodde, N, et al.
Life Sciences. 2015 April 25 (abstract).
Felilú, A, at al.
British Journal of Pharmacology. 2015 April 8 (abstract).
Current status and future of cannabis research.
Russo, Ethan B, et al.
Clinical Researcher. 2015 April 58.
Introduction to the endocannabinoid system.
Russo, Ethan
Phytex Website. 2015.
Finseth, Taylor Andrew, et al.
Evidence Based Complementary and Alternative Medicine. 2015 article ID 874849.
Kvitland, Levi Roestad, et al.
BMC Psychiatry. 2015 15: 11.
Phytocannabinoids and epilepsy.
dos Santos, R G, et al.
Journal of Clinical Pharmacy and Therapeutics. 2015 April 40(2): 135-143.
Gòmez-Gálvez, Y, et al.
Progress in Neuropsychopharmacology & Biological Psychiatry. 2015 April 9 (abstract).
Efficacy of inhaled cannabis on painful diabetic neuropathy.
Wallace, M S, et al.
Journal of Pain. 2015 April 2 (abstract).
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.
Press, C A, et al.
Epilepsy & Behavior. 2015 April 2 (abstract).
Kramer, Joan L.
CA A Cancer Journal for Clinicians. 2015 March/April 65(2): 109-122.
Bechtold, Jordan, et al.
Psychology of Addictive Behaviors. 2015 29(3): 552-563.
Loflin, Mallory, et al.
Canadian Journal of Respiratory Therapy. 2015 51(1): 7-9.
The therapeutic potential of cannabinoids for movement disorders.
Kluger, Benzi, et al.
Movement Disorders.2015 30(3): 313-327.
Kogan, N M, et al.
Journal of Bone and Mineral Research. 2015 March 19 (abstract).
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
Armstong, Jane L, et al.
Journal of Investigative Dermatology. 2015 March 12 135: 1629-1637.
Di Forti, Marta, et al.
The Lancet Psychiatry. 2015 March 2(3): 233-238.
Cannabis use in relation to obesity and insulin resistance in the Inuit population.
Ngueta, Gerard et al.
Obesity. 2015 February 23(2).
Medical marijuana for digestive disorders: high time to prescribe?
Gerich, Mark E, et al.
The American Journal of Gastroenterology. 2015 February 110: 208-214.
Ahmed, Amir I A, et al.
Psychopharmacology. 2015 232: 2587-2595.
van der Meer, F J, et al.
Psychological Medicine. 2015 Feb. 5:1-12 (abstract).
Cannabis use in relation to obesity and insulin resistance in the Inuit population.
Ngueta, G, et al.
Obesity. 2015 Feb. 23 (2): 290-295 (abstract).
Morales, P, et al.
Journal of Medicinal Chemistry. 2015 Feb. 20 (abstract).
Monteleone, A M, et al.
American Journal of Clinical Nutrition. 2015 Feb. 101(2): 262-269 (abstract).
Gallily, Ruth, et al.
Pharmacology & Pharmacy. 2015 Feb.10, 6: 75-85.
Thomas, A A, et al.
Urology. 2015 Feb. 85(2): 388-393 (abstract).
Synthetic and natural cannabinoids: the cardiovascular risk.
Russo, Ethan B
The British Journal of Cardiology. 2015 22(1) January-March: 7-9.
Lachenmeier, Dirk W, et al.
Scientific Reports. 2015 Jan. 30.
Rahimi, A, et al.
Neuroscience. 2015 Jan.28: 290C: 279-287 (abstract).
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults.
Weiland, Barbara, J, et al.
The Journal of Neuroscience. 2015 January 28 35(4): 1505-1512.
Proapoptotic effect of endocannabinoids in prostate cancer cells.
Orellana-Serradell, O, et al.
Oncology Reports. 2015 Jan. 21.
Feng, R, et al.
Molecular Carcinogenesis. 2015 Jan. 16 (abstract).
Jetly, R, et al.
Psychoneuroendocrinology. 2015 Jan. 15, 51: 585-588 (abstract).
Two non-psychoactive cannabinoids reduce intra-cellular lipid levels and inhibit hepatosteatosis.
Silvestri, C, et al.
Journal of Hepatology. 2015 Jan. 13 (abstract).
de Campos, A C, et al.
Neuroscience. 2015 Jan. 13 (abstract).
Soliman, E, et al.
Molecular Carcinogenesis. 2015 Jan. 3 (abstract).
The conversation and transfer of cannabinoids from cannabis to smoke stream in cigarettes.
Elzinga, Sytze, et al.
Natural Products and Chemistry Research. 2015 3 (1).
Medical cannabis healthcare provider info.
Sulak, D.
Healer.com 2015.
Sulak, D.
Healer.com. 2015.
2014
Pertwee, Roger (ed.)
Oxford University Press. 2014 (see separate book).
The combination of cannabidiol and ?9-tetrahydrocannabinol enhances murine glioma model.
Scott, Katherine A, et al.
Molecular Cancer Therapeutics. 2014 13(12): 2955-2967.
Greco, Rosaria, et al.
The Journal of Headache and Pain. 2014, 15:14.
Gui, H, et al.
Immunobiology. 2014 Dec.30 (abstract).
Medical marijuana laws and suicides by gender and age.
Anderson, DM, et al.
American Journal of Public Health. 2014 Dec. 104(12): 2369-2376 (abstract).
Jenkin, KA, et al.
Clinical and Experimental Pharmacology & Physiology. 2014 Dec. 29 (abstract).
Tudge, L, et al.
International Journal of Neuropsychopharmacology. 2014 Dec.25.
Bagüés, A, et al.
European Journal of Pharmacology. 2014 Dec. 15, 745:69-75 (abstract).
Chauvet, C, et al.
International Journal of Neuropsychopharmacology. 2014 Dec.5.
Degenhardt, L, et al.
Drug Alcohol Dependence. 2014 Dec. 10 (abstract).
Kempker, JA, et al.
Annals of the American Thoracic Society. 2014 Dec. 18 (abstract).
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration.
Silveira, JW, et al.
PLoS One. 2014 Dec. 17 9(12).
Scott, Katherine A, et al.
Molecular Cancer Therapeutics. 2014 Dec. 13 (12): 2955-67 (abstract).
Zhang, J, et al.
Journal of Cerebral Blood Flow & Metabolism. 2014 Dec. 10 (abstract).
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice.
Neelakantan, H, et al.
Behavioral Pharmacology. 2014 Dec. 5 (abstract).
Gross morphological brain changes with chronic, heavy cannabis use.
Lorenzetti, V, et al.
British Journal of Psychiatry. 2014 Nov. 27 (abstract).
Rao, R, et al.
British Journal of Pharmacology. 2014 Nov. 26 (abstract).
Early phytocannabinoid chemistry to endocannabinoids and beyond.
Mechoulam, Raphael, et al.
Nature Reviews/Neuroscience 2014 Nov. 15: 757-764.
Viana, TG, et al.
Psychopharmacology(Berl.). 2014 Nov. 13 (abstract).
Milloy, MJ, et al.
Drug Alcohol Review. 2014 Nov. 11 (abstract).
Zhang, Hai-Ying, et al.
Proceedings of the National Academy of Sciences. 2014 Nov. 3 E5007-E5015.
Effect of marijuana use on outcomes in traumatic brain injury.
Nguyen, B M, et al.
American Journal of Surgery. 2014 Oct. 80(10): 979-83 (abstract).
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Sexton, M, et al.
Inflammopharmacology. 2014 Oct, 22(5): 295-303 (abstract).
Tchantchou, F, et al.
Neuropharmacology. 2014, Oct. 85: 427-39 (abstract).
Cameron, C, et al.
Journal of Clinical Psychopharmacology. 2014 Oct, 34(5): 559-564.
Legalization of medical marijuana and incidence of opioid mortality.
Hayes, Marie J, et al.
JAMA Internal Medicine. 2014, 174(10): 1673-1674 (abstract).
Borrelli, F, et al.
Carcinogenesis. 2014 Sep. 30 (abstract).
Pietrzak, Robert H, et al.
Neuropsychopharmacoloy. 2014, 39:2519-2528 (abstract).
Smith, P H, et al.
Psychology of Addictive Behaviors. 2014 Sep, 28(3): 734-742 (abstract).
Cannabidiol improves vasorelaxation in Zucker Diabetic fatty rats through cyclooxygenase activation.
Wheal, A J, et al.
Journal of Pharmacology and Experimental Therapeutics. 2014 Sep. 11 (abstract).
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability.
Freidel, M, et al.
Acta Neurologica Scandinavica. 2014 Sep. 11.
Salaga, M, et al.
Journal of Chronic Colitis. 2014 Sep 1, 8(9): 998-1009.
Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.
Bachhuber, M A, et al.
JAMA Internal Medicine. 2014 Aug. 25 (abstract).
Preliminary, open-label, pilot study of add-on oral ?9-tetrahydrocannabinol in chronic post-traumatic stress disorder.
Roitman, P, et al.
Clinical Drug Investigation. 2014 Aug, 34(8): 587-591 (abstract).
Cheng, Y, et al.
Pharmacology. 2014 Aug, 94(1-2): 1-12 (abstract).
Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.
Aso, E, et al.
Journal of Alzheimers Disease. 2014, Aug. 14 (abstract).
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1Δ E9 Mice.
Cheng, D, et al.
Psychopharmacology. 2014 Aug, 231(15): 3009-3017 (abstract).
Haustein, M, et al.
Biochemical Pharmacology. 2014 Jul. 25, 15:92 (abstract).
Giordano, G N, et al.
Psychological Medicine. 2014 Jul. 3: 1-8 (abstract).
The impact of cannabis use on clinical outcomes in recent onset psychosis.
Barrowclough, C, et al.
Schizophrenia Bulletin. 2014 July 9 (abstract).
Does the legalization of medical marijuana increase completed suicide?
Rylander, M, et al.
The American Journal of Drug and Alcohol Abuse. 2014 Jul, 40(4): 269-273.
Kander, Justin
5th edition 2014 July (separate binder).
Genetic predisposition to schizophrenia associated with increased use of cannabis.
Power, R A, et al.
Molecular Psychiatry. 2014 19: 1201-1204.
Cannabis smoking and lung cancer risk: pooled analysis in the international lung cancer consortium.
Zhang, L R, et al.
International Journal of Cancer. 2014 Jun 30.
Type-1 cannabinoid receptor activity during Alzheimer’s disease progression.
Manuel, I, et al.
Journal of Alzheimers Disease. 2014 Jun 19, 42(3): 761-766 (abstract).
Genetic predisposition to schizophrenia associated with increased use of cannabis.
Power, R A, et al.
Molecular Psychiatry. 2014 Jun 24, EISSN: 1476-5578 (abstract).
Flachenecker, P, et al.
European Neurology. 2014 Jun 18, 72(1-2): 95-102 (abstract).
Patterns of use of medical cannabis among Israeli cancer patients: a single institution experience.
Waissengrin, B, et al.
Journal of Pain Symptom Management. 2014 Jun 14, pii: S0885-3924(14)00312-1 (abstract).
Bahi, A, et al.
Physiology & Behavior. 2014 Jun 13, 135C: 119-124 (abstract).
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.
Grassin-Delyle, S, et al.
British Journal of Pharmacology. 2014 Jun, 171(11): 2767-2777 (abstract).
Chagas, M H, et al.
Journal of Clinical Pharmacy and Therapeutics. 2014 May 21, 2014 Oct, 39(5): 564-566 (abstract).
Cannabis and cannabinoids (PDQ). health professional version.
National Cancer Institute. May 13 2014.
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity.
Castelli, Paola M, et al.
PLoS One. 2014: 9(5): e98079.
Impact of substance use on conversion to psychosis in youth at clinical high risk of psychosis.
Buchy, L, et al.
Schizophrenia Research. 2014 May, 156(2-3): 277-280 (abstract).
Koppel, Barbara S, et al.
Neurology. 2014 April 29: 1556-1563.
Klauke, A L, et al.
European Neuropsychopharmacology. 2014 Apr, 24(4): 608-620 (abstract).
Tambaro, S, et al.
European Journal of Pharmacology. 2014 Apr 15, 729: 67-74 (abstract).
Wong, A, et al.
Psychopharmacology. 2014 Apr 3 (abstract).
Lotan, I, et al.
Clinical Neuropharmacology. 2014 Mar-Apr, 37(2): 41-44 (abstract).
Rodriguez-Cueto, C, et al.
Pathobiology. 2014 Mar 14, 81(3): 49-159 (abstract).
Anandamide inhibits breast tumor-induced angiogenesis.
Picardi, P, et al.
Translational Medicine. 2014, 10(3): 8-12.
Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use.
Loflin, Mallory, et al.
Substance Use & Misuse. 2014 Mar, 49(4): 427-434 (abstract).
Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration.
Lax, Pedro, et al.
Experimental Eye Research. 2014 Mar, 120: 175-185 (abstract).
Lotan, I, et al.
Clinical Neuropharmacology. 2014 Mar, 37(2): 41-44 (abstract).
McPartland, John M, et al.
PLOS One. 2014 Mar, 9(3): 1-21.
That which we call Indica, by any other name would smell as sweet.
Erkelens, Jacob L, et al.
Cannabinoids. 2014, 9(1): 9-15.
Flachenecker, P, et al.
European Neurology. 2014, 71(5-6): 271-279 (abstract).
Florek-Luszczki, Magdalena, et al.
Journal of Neural Transmission. 2014 Feb 19, 121(7): 707-715.
Schiavon, A P, et al.
Neurotoxicity Research. 2014 Feb 15 (abstract).
Cannabidiol as a potential treatment for psychosis.
Schubart, C D, et al.
European Neuropsychopharmacology. 2014 Jan, 24(1): 51-64 (abstract).
Armentano, Paul
The National Organization for the Reform of Marijuana Laws. Jan 13 2014: 1-69 (see separate binder).
Cannabis in neurology-a potted review.
Hosking, Richard, et al.
Nature Reviews Neurology. 2014 10: 429-430.
Harvey, B S, et al.
Cytokine. 2014 Feb, 65(2): 236-244 (abstract).
Ward, S J, et al.
British Journal of Pharmacology. 2014 Feb, 171(3): 636-645.
A controlled family study of cannabis users with and without psychosis.
Proal, A C, et al.
Schizophrenia Research. 2014 Jan, 152(1): 283-288 (abstract).
Smith, S C, et al.
Neuro Endocrinology Letters. 2014 35(3): 198-201 (abstract).
2013
Cannabis inflorescence, Cannabis spp. Standards of identity, analysis, and quality control.
Upton, Roy, et al.
American Herbal Pharmacopoeia. 2013 Dec, (see separate binder).
Bossong, Matthijs G, et al.
European Neuropsychopharmacology. 2013 Dec, 23(12): 1687-1697.
Marijuana use patterns among patients with inflammatory bowel disease.
Ravikoff Allegretti, Jessica, et al.
Inflammatory Bowel Diseases. 2013 Dec, 19(13): 2809-2814.
Impact of ADHD and cannabis use on executive functioning in young adults.
Tamm, Leanne, et al.
Drug and Alcohol Dependence. 2013 December 1 133(2).
Amada, Naoki, et al.
Peer Journal. 2013 Nov 21, 1: e214.
Risk of road-accident associated with the use of drugs: a systematic review and meta-analysis of
evidence from epidemiological studies.
Elvik, R
Accident Analysis and Prevention. 2013 Nov. 60:254-267 (abstract).
Scott, K A, et al.
Anticancer Research. 2013 Oct, 33(10): 4373-4380 (abstract).
Calik, M W, et al.
Respiratory Physiology & Neurobiology. 2013 Oct, 190: 20-24.
Naftali, Timna, et al.
Clinical Gastroenterology and Hepatology. 2013 Oct, 11(10): 1276-1280 (abstract).
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes.
Stanley, C P, et al.
European Journal of Pharmacology. 2013 Oct 8, 720(1-3): 376-382 (abstract).
Sub-types of attention deficit-hyperactivity disorder (ADHD) and cannabis use.
Loflin, M, et al.
Substance Use & Misuse. 2013 Oct 4, 49(4): 427-434 (abstract).
Greydanus, Donald E, et al.
Frontiers in Public Health 2013 October Article 42.
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
Cooper, Z D, et al.
Neuropsychopharmacology. 2013 Sep, 38(10): 1984-1992.
Brunet, Laurence, et al.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2013 Sep 1, 57(5): 663-670.
Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.
Morgan, C J, et al.
Addiction Behaviors. 2013 Sep, 38(9): 2433-2436 (abstract).
Neumeister, Alexander, et al.
Molecular Psychiatry. 2013 Sep, 18(9): 1034-1040.
Comparison of the analgesic effects of Dronabinol and smoked marijuana in daily marijuana smokers.
Cooper, Z D, et al.
Neuropsychopharmacology. 2013 Sep, 38(10): 1984-1992.
Cholewa, K M, et al.
AlterNet.org. 2013 Aug 18, online article.
Hazekamp, A, et al.
Journal of Psychoactive Drugs. 2013 Jul-Aug, 45(3): 199-210 (abstract).
Bar-Sela, Gil, et al.
Evidence-based Complementary and Alternative Medicine. 2013, e510392.
An ultra-low dose of tetrahydrocannabinol provides cardioprotection.
Waldman, M, et al.
Biochemical Pharmacology. 2013 Jun 1, 85(11): 1626-1633 (abstract).
Effects of marijuana smoking on the lung.
Annals of the American Thoracic Society. 2013 Jun, 10(3): 239-247.
Wargent, E T, et al.
Nutrition and Diabetes. 2013 May 27, 3, e68.
Lee, Martin, A
High Times. May 2013.
THC can prevent brain damage – study.
Science 2.0, 2013 May 30.
Katsuyama, S, et al.
European Journal of Pain. 2013 May 17(5): 664-675 (abstract).
High on health: cannabinoids in the food supply.
Badiner, Alan
www.wakingtimes.com. 2013 Apr 25.
Cannabinergic pain medicine: a concise primer and survey of randomized-controlled trial results.
Aggarwal, S K
Clinical Journal of Pain. 2013, Feb 29(2): 162-171 (abstract).
Low dose vaporized cannabis significantly improves neuropathic pain.
Wilsey, Barth, et al.
Journal of Pain. 2013 Feb 14(2): 136-148.
Information for health care professionals. Cannabis (marihuana, marijuana) and cannabinoids.
Health Canada. February 2013 (see separate binder).
Armentano, Paul
NORML. 29 Jan 2013.
Role of cannabinoids in pain management.
Russo, Ethan B, et al.
Comprehensive treatment of chronic pain by medical, interventional and integrative approaches.
Deer, T.R., et al. (eds.), American Academy of Pain Medicine 2013, 181-197.
Pregnancy, breast feeding, and marijuana: a review article.
Hill, Meg, et al.
Obstetrical And Gynecological Survey. 2013 68(10): 710-718.
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults.
Penner, Elizabeth A, et al.
The American Journal of Medicine. 2013 126(7): 583-589.
Modulating the endocannabinoid system in human health and disease: successes and failures.
Pacher, Pál, et al.
Federation of European Biochemical Societies (FEBS) Journal. 2013 280(9): 1918-1943.
Critical appraisal of the potential use of cannabinoids in cancer management.
Cridge BJ, et. al
Cancer Management Research. 2013 5:301–13.
2012
Medical marijuana: clearing away the smoke.
Grant, Igor, et al.
The Open Neurology Journal. 2012, 6: 18-25.
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Leweke, F M, et al.
Translational Psychiatry. 2012 2 e94.
Cannabidivarin is anticonvulsant in mouse and rat.
Hill, A J, et al.
British Journal of Pharmacology. 2012 Dec, 167(8): 1629-1642.
Takeda, Shuso, et al.
Toxicol.Lett. 2012 Nov.15 214(3): 314-319.
Cannabinoids: a new hope for breast cancer therapy?
Caffarel, M M, et al.
Cancer Treatment Reviews. 2012 Nov. 38(7): 911-918 (abstract).
Cannabis – from cultivar to chemovar.
Drug Testing and Analysis. 2012 Jul-Aug; 4(7-8): 660-7.
De Backer, B, et al.
Journal of Forensic Sciences. 2012 July 57(4): 918-922 (abstract).
Cannabis – a valuable drug that deserves better treatment.
Mechoulam, Raphael
Mayo Clinic Proceedings. 2012 Feb, 87(2): 107-109.
Cannabinoid hyperemesis: a case series of 98 patients.
Simonetto, D A, et al.
Mayo Clinic Proceedings. 2012 Feb, 87(2): 114-119.
Blurred boundaries: the therapeutics and politics of medical marijuana.
Bostwick, Michael J
Mayo Clinic Proceedings. 2012 Feb, 87(2): 172-186.
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer Disease.
D’Addario, Claudio, et al.
PLoS One. 2012, 7(6): e39186.
Aroma therapy.
Gardner, Fred
Medical Marijuana. 2012, 29-34.
Cannabidiol inhibits lung cancer cell invasion and metastasis.
Ramer, Robert, et al.
The FASEB Journal, 2012 Apr, 1235-1248.
Izzo, Angelo, et al.
British Journal of Pharmacology. 2012 Jun, 166(4): 1444-1460.
Armento, Paul, et al.
NORML Foundation. 2012 Mar 14.
Rajavashisth, Tripatith B, et al.
BMJ OPEN. 2012 2.
Naturally occurring anxiolytic substances from aromatic plants of genus citrus.
Pimenta, Flavia Cristina Fernandes, et al.
Journal of Medicinal Plants Research. 2012 Jan 23, 6(3): 342-347.
Association between marijuana exposure and pulmonary function over 20 years.
Pletcher, Mark J, et al.
JAMA. 2012 January 11 307(2): 173-181.
Ramos, Juan A, et al.
Indian Journal of Urology. 2012 Jan, 28(1): 9-14.
Cannabidiol enhances anandamide signaling and alleviates psychotic symptomes of schizophrenia.
Leweka, F M, et al.
Translational Psychiatry. 2012, e94.β
2011
The endocannabinoid system and cancer: therapeutic implication.
Guindon, Josee, et al.
British Journal of Pharmacology. 2011, 163: 1447-1467.
Esposito, Giuseppe, et al.
PloS ONE. 2011 6(12): e28668.
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, Ethan B.
British Journal of Pharmacology. 2011, 163: 1344-1364.
Spaulding, Nathan
Cannabishealthnewsmagazine.com. 2011 Nov.
McAllister, Sean D, et al.
Breast Cancer Research and Treatment. 2011 August 129(1): 37-47.
Garcia, C, et al.
British Journal of Pharmacology. 2011 Aug, 163(7): 1495-150.
Obesity and cannabis use: results from 2 representative national surveys.
Le Strat, Yann, et al.
American Journal of Epidemiology. 2011 Aug. 24.
Shrivastava, Ashutosh, et al.
Molecular Cancer Therapeutics. 2011 July 10(7): 1161-1172.
Reinarman, Craig, et al.
Journal of Psychoactive Drugs. 2011, 43(2): 128-135 (abstract).
Booklets on cannabis and specific medical conditions.
Americans for Safe Access (ASA). 2011 Feb.
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
Lynch, Mary E, et al
British Journal of Pharmacology. 2011 72(5): 735-744.
Ruhaak, Lucia Renee, et al.
Biological and Pharmaceutical Bulletin. 2011 34(5): 774-778.
Huang, Li, et al.
Laboratory Investigation. 2011 91: 1007-1017.
Lorente, M, et al.
Cell Death and Differentiation. 2011 18: 959-973.
2010
Cannabinoids and the gut: New developments and emerging concepts.
Izzo, Angelo A, et al.
Pharmacology & Therapeutics. 2010 126: 21-38 (abstract).
Blázquez, Cristina, et al.
Brain.2010 October 7.
Morgan, Celia J A, et al.
Neuropsychopharmacology. 2010 Aug, 35(9): 1879-1885.
Cannabinoids reduce erbB2-driven breast cancer progression through akt inhibition.
Caffarel, María M, et al.
Molecular Cancer. 22 July 2010, 9 196.
Hypotensive activity of terpenes found in essential oils.
Menezes, Igor A C, et al.
Zeitschrift für Naturforschung.2010 June 65c: 562-566.
The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation pain in mice.
Bolognini, Daniele, et al.
British Journal of Pharmacology. 2010 Jun, 160(3): 677-687.
Bhattacharyya, Sagnik, et al.
Neuropsychopharmacology. 2010 Feb, 35(3): 764-774.
Review on clinical studies with cannabis and cannabinoids 2005-2009.
Hazekamp, Arno, et al.
Cannabinoids. 2010, 5 (special issue): 1-21.
Marcu, Jahan, et al.
Molecular Cancer Therapeutics. 2010 January 9(1): 180-189.
Fischedick, Justin Thomas, et al.
Phytochemistry. 2010 71: 2058-2073.
Wolf, Susanna A, et al.
Cell Communication and Signaling. 2010, 8: 12 (abstract).
Cannabinoids and the gut: new developments and emerging concepts.
Izzo, Angelo A, et al.
Pharmacology & Therapeutics. 2010, 126: 21-28.
2009
Hazekamp, Arno.
Department of Plant Metabolomics, Leiden University, Leiden. The Netherlands. 2008-2009 (see separate binder).
Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Pertwee, Roger G, et al.
British Journal of Pharmacology. 2009 156: 397-411.
Smoking marijuana does not cause lung cancer, Tashkin reiterates to patients out of time.
Gardner, Fred.
O’Shaughnessy’s. 2009 Summer.
Fraser, G A.
CNS Neuroscience & Therapeutics. 2009 Winter, 15(1): 84-88 (abstract).
Ren, Yanhua, et al.
The Journal of Neuroscience. 2009 Nov 25, 29(47): 14764-14769.
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Izzo, Angelo A, et al.
Trends in Pharmacological Sciences. 2009 30(10) (abstract).
Rogerio, Alexandre P, et al.
British Journal of Pharmacology. 2009 Oct, 15(4): 1074-1087.
A population-based case-control study of marijuana use and head and neck squamous cell carcinoma.
Liang, C, et al.
Cancer Prevention Research (Phila). 2009 Aug, 2(8): 756-768 (abstract).
Oesch, Susanne, et al.
Molecular Cancer Therapeutics. July 2009; 8(7): 1838-1845.
2008
DeMorrow, Sharon, et al.
American Journal of Physiological Gastrointestinal and Liver Physiology. 2008 Dec. 295(6):
G1150-G1168.
Svízenská, Ivana, et al.
Pharmacology, Biochemistry and Behavior. 2008 90: 501-508.
Cannabis improves symptoms of ADHD.
Strohbeck-Kuehner, Peter, et al.
Cannabinoids. 2008, 3(1): 1-3.
El-Remessy, A B, et al.
Molecular Vision. 2008, 14: 2190-2203.
Cormelli, F, et al.
Phytotherapeutic Research. 2008, 22(8): 1017-1024 (abstract).
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.
Zuardi, Antonio Waldo
Revista Brasileira de Psiquiatria. 2008, Sep, 30(3).
Cannabidiol, extracted from cannabis sativa selectively inhibits hypermotility in mice.
Capasso, R, et al.
British Journal of Pharmacology. 2008 May 12, 154(5): 1001-1008.
Cannabinoids in the management of difficult to treat pain.
Russo, Ethan B
Therapeutics and Clinical Risk Management. 2008, 4(1): 245-259.
Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom.
Gilani, Anwarul Hassan, et al.
Journal of Ethnopharmacology. 2008 Feb 12, 115(3): 463-472 (abstract).
Pertwee, R G
British Journal of Pharmacology. 2008 Jan, 153(2): 199-215.
Influence on cannabis use on severity of hepatitis C disease.
Ishida, Julie H, et al.
Clinical Gastroenterology and Hepatology. 2008 Jan, 6(1): 69-75.
2007
Cannabidiol as a novel inhibitor of ld-1 gene expression in aggressive breast cancer cells.
McAllister, Sean D, et al.
Molecular Cancer Therapeutics. 2007 November 6(11): 2921-2927.
Human cannabinoid pharmacokinetics.
Huestis, Marilyn A, et al.
Chemistry & Biodiversity. 2007 August 4(8): 1770-1804.
Opposing actions of endocannabinoids on cholangiocarcinoma growth.
DeMorrow, Sharon, et al.
The Journal of Biological Chemistry. 2007 April 27, 282(17): 13098-13113.
Marijuana cuts lung cancer tumor growth in half, study shows.
American Association for Cancer Research
Sciencedaily.com. 2007 Apr 17.
Rivazi, A, et al.
Planta Medica. 2007 Apr, 73(4): 355-362 (abstract).
Cannabis in painful HIV-associated sensory neuropathy. A randomized placebo-controlled trial.
Abrams, D I, et al.
Neurology. 2007 68: 515-521.
Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea.
Hazekamp, Arno, et al.
Journal of Ethnopharmacology. 2007 113: 85-90.
Wilkinson, J D, et al.
Journal of Dermatological Science. 2007 Feb, 45(2): 87-92 (abstract).
Screening of antibacterial activities of twenty-one oxygenated monoterpenes.
Kotan, Recep, et al.
Zeitschrift fur Naturforschung.2007, 62c: 507-513 (abstract).
Sedative effect of monoterpene alcohols in mice: a preliminary screening.
de Sousa, Damiao Pergentino, et al.
Zeitschrift fur Naturforschung. 2007, 62c: 563-566 (abstract).
D-Limonene: safety and clinical applications
Sun, Jidong, et al.
Alternative Medicine Review. 2007, 12(3): 259-264.
Dosing medical marijuana: rational guidelines on trial in Washington State.
Sunil, K, et al.
Medscape General Medicine. 2007, 9(3) 52.
2006
Hashibe, Mia, et al.
Cancer Epidemiology, Biomarkers & Prevention. 2006 October 15(10): 1829-1834.
Russo, Ethan, et al.
Medical Hypothesis. 2006, 66: 234-246.
Verhoeckx, Kitty C M, et al.
International Immunopharmacology. 2006 6: 656-665.
Endocannabinoid mechanisms of pain modulation.
Hohmann, Andrea G, et al.
The AAPS Journal. 2006 8(4): E693-E708.
Holdcroft, Antita, et al.
Anesthesiology. 2006, 104(5): 1040-1046 (abstract).
Hazekamp, Arno, et al.
Journal of Pharmaceutical Sciences. 2006, 95(6): 1308-1317 (abstract).
Interaction between terpenes and penicillin on bacterial strains resistant to beta-lactam antibiotics.
Gallucci, N, et al.
Molecular Medicinal Chemistry. 2006, 10: 30-32.
History of cannabis as a medicine: a review.
Zuardi, Antonio Waldo
Revista Brasileira de Psiquiatria. 2006, 28(2): 153-157.
Cannabidiol, a cannabis sativa constituent, as an antipsychotic drug.
Zuardi, A W, et al.
Brazilian Journal of Medical and Biological Research. 2006, 39(4): 421-429.
Shmist, Y A, et al.
Molecular Cell Biochemistry. 2006 Feb. (abstract).
Ligresti, Alessia, et al.
The Journal of Pharmacology and Experimental Therapeutics. 2006 318(3): 1375-1387.
Endocannabinoid mechanisms of pain modulation.
Hohmann, Andrea G, et al.
The AAPS Journal. 2006 Nov. 17 8(4): E693-708.
Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek, Orr, et al.
Proceedings of the National Academy of Sciences. 2006 January 17 103(3): 696-701.
2005
Thomas, Adele, et al.
British Journal of Pharmacology. 2005 Dec, 146(7): 917-926.
McKallip, Robert J, et al.
Journal of Immunology. 2005 174: 3281-3289.
Immunomodulatory and therapeutic properties of the Nigella sativa L. seed.
Salem, Mohammed Labib
International Immunopharmacology. 2005, 5: 1749-1770 (abstract).
Involvement of cannabinoids in cellular proliferation.
Lopez-Rodriguez, Maria L, et al.
Mini-Reviews in Medicinal Chemistry. 2005, 5: 97-106 (abstract).
Antileishmanial activity of the terpene nerolidol.
Arruda, Denise C, et al.
Antimicrobial Agents and Chemotherapy, 2005, 49(5): 1679-1687.
Ständer, S, et al.
Journal of Dermatological Science. 2005 June 38(3): 177-188.
Chemical constituents of marijuana: the complex mixture of natural cannabinoids.
ElSohly, Mahmoud A, et al.
Life Sciences. 2005 78: 539-548.
2004
Survey on cannabis use in Parkinson’s disease: subjective improvement of motor symptoms.
Venderova, Katerina, et al.
Movement Disorders. 2004 Sep, 19(9): 1102-1106 (abstract).
Medveczky, Peter G, et al.
BMC Medicine. 2004 2: 34
Cannabis, cannabinoids and reproduction.
Park, Boram, et al.
Prostaglandins, Leukotrienes and Essential Fatty Acids. 2004, 70: 189-197.
Giuffrida, Andrea, et al.
Neuropsychopharmacology. 2004 29: 2108-2114.
Cannabis for dyskinesia in Parkinson’s disease. A randomized double-blind crossover study.
Carroll, C B, et al.
Neurology. 2004 Oct 12, 63(7): 1245-1250 (abstract).
Avraham, Y, et al.
Pharmacology Biochemistry and Behavior. 2004 Apr, 77(4): 675-684 (abstract).
Medicinal cannabis: rational guidelines for dosing.
Carter, Gregory T, et al.
Drugs.2004 May 7(5): 464-470.
Russo, E B
Neuroendocrinology Letters. 2004 Feb-Apr, 25(1-2): 31-39 (abstract).
Chronic conditions treated with cannabis. Encountered between 1990-2004. “Dr. Tod’s List.”
Mikuriya, Tod.
2004.
Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action.
Narishetty, Sunil Thomas Kumar, et al.
Journal of Controlled Release. 2004 Mar 24, 95(3): 367-379 (abstract).
2003
The therapeutic potential of cannabis.
Baker, David, et al.
The Lancet Neurology. 2003 May, 2(5): 291-298 (abstract).
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study.
Grant, Igor, et al.
Journal of the International Neuropsychological Society. 2003 9: 679-689.
Vigna, Steven R,.
Gastroenterology. 2003 Sept. 125: 973-975 (editorial).
Possible endocannabinoid control of colorectal cancer growth.
Ligresti, Alessia et al.
Gastroenterology. 2003 Sept. 125: 677-687.
Bearman, David
http://www.davidbearman.com. 2003.
Iversen, Leslie
Brain. 2003, 126: 1252-1270.
Guidelines for cultivating cannabis for medicinal purposes.
Scholten, Willem K
Journal of Cannabis Therapeutics. 2003, 3(2): 51-61.
The inheritance of chemical phenotype in cannabis satival L.
Meijer, Etienne P M de
Genetics. 2003 Jan 1, 163(1): 335-346.
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.
Izzo, Angelo A, et al.
Gastroenterolology. 2003 Sept. 125: 765-774.
2002
The endogenous cannabinoid system controls extinction of aversive memories
Giovanni M, et.al
Nature. 418, 530-534 (2002).
A cDna clone for β-caryophyllene synthase from Artemisia annua.
Cai, Yu, et al.
Phytochemistry. 2002 Nov, 61(5): 523-529 (abstract).
Chronic cannabis use in the compassionate investigational new drug program:
an examination of benefits and adverse effects of legal cannabis.
Russo, Ethan, et al.
Journal of Cannabis Therapeutics. 2002 2(1): 3-57.
2001
Pharmacological actions and therapeutic uses of cannabis and cannabinoids.
Kumar, R N, et al.
Anaesthesia. 2001 Nov, 56(11): 1059-1068 (abstract).
Cannabis and cannabis extracts: greater than the sum of their parts?
McPartland, John, et al.
Hayworth Press. 2001.
2000 – 1843
Cannabinoids in clinical practice.
Williamson, Elizabeth, et al.
Drugs. 2000 Dec, 60(6): 1303-1314 (abstract).
Malfait, A M, et al.
Proceedings of the National Academy of Sciences. 2000, 97(17): 9561-9566.
Prevention and therapy of cancer by dietary monoterpenes.
Crowell, Pamela L
Journal of Nutrition. 1999, 129(3): 775s-778s.
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
De Petrocellis, Luciano, et al.
Proceedings of the National Academy of Sciences USA. 1998 July 95: 8375-8380.
Ben-Shabat, Shimon, et al.
European Journal of Pharmacology. 1998 353: 23-31 (abstract).
Essential oil of cannabis sativa L. strains.
Mediavilla, Vito, et al.
Journal of the International Hemp Association. 1997, 4(2): 82-85.
Yu, Suzanne G, et al.
Journal of Nutrition. 1995, 125(11): 2763-2767 (abstract).
Pate, David W
Journal of the International Hemp Association. 1994, 2: 29, 32-37.
Action of cannabidiol on the anxiety and others effects produced by ?9-thc in normal subjects.
Zuardi, A W, et al.
Psychopharmacology. 1982 76: 245-250 (abstract).
Subacute cannabinoid treatment: anticonvulsant activity and withdrawal excitability in mice.
Karler, Ralph
British Journal of Pharmacology. 1980 Mar, 68(3): 479-484.
On the preparation of the Indian hemp or gunjah.
O’Shaughnessy, W B, et al.
Provincial Medical Journal. 1843, no. 123: 363-369.